Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

ROCHE DIAGNOSTICS CORP

Roche Diagnostics Corporation is the North American headquarters of Roche Diagnostics, a global leader in diagnostics... read more Featured Products: More products

Download Mobile App





Roche Diagnostics Highlights Latest Clinical Lab Solutions at AACC

By LabMedica International staff writers
Posted on 02 Aug 2018
Roche Diagnostics (Basel, Switzerland) will launch its presence at the American Association for Clinical Chemistry (AACC) 2018 Clinical Lab Expo at the McCormick Place Convention Center today by showcasing how laboratories are driving change at integrated health networks by turning challenges associated with the Protecting Access to Medicare Act (PAMA) into opportunities to optimize both lab operations and clinical decision-making processes.

Roche is the world's largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. More...
Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management.

The Roche booth (#1212) will feature presentations about thought-leading labs that have performed comprehensive analyses of their service systems and then streamlined processes to improve productivity, reduce costs and successfully address the reimbursement impact of PAMA and other factors. At its media briefing at the convention, Roche management will address new initiatives in the company's digital diagnostics portfolio that focus on workflow and clinical decision support. In addition, a representative from a Chicago-area health network will discuss how the laboratory is harnessing data to drive decisions that have broad impact beyond the lab, such as reducing the incidence of healthcare-associated infections and the unnecessary use of antibiotics.

The Roche booth will also feature the latest solutions from the company's entire clinical lab portfolio, including chemistry, molecular, tissue and point-of-care diagnostics, automation and digital diagnostics. The automation area will include a fully automated configuration of an integrated core lab that consolidates routine chemistry and molecular testing.

Highlighted products in the booth include:

cobas e 801 module – high-volume immunoassay platform that provides nearly twice the throughput on the same footprint as its predecessor.
cobas c 513 analyzer—fully automated chemistry platform that raises the standard in HbA1c testing throughput.
cobas 6800 system—fully automated, moderate-complexity platform that brings transformational efficiency gains to molecular diagnostics.
cobas Connection Module (CCM)—high-volume automation solution that provides connectivity across disciplines and third-party platforms.
cobas Liat PCR system—point-of-care analyzer with CLIA-waived, real-time PCR tests for flu A/B, flu A/B + RSV and strep A that provide lab-quality results in 20 minutes or less.
cobas m 511 integrated hematology analyzer—automated system that uses a standardized slide-making and staining process, digital multi-spectral imaging and advanced algorithms to optimize cell counting and classification.

The booth also includes a futures area that offers a glimpse into diagnostics products that are not yet available for sale in the U.S.

In addition, Roche is continuing its commitment to discussing critical industry issues by sponsoring four workshops in conjunction with the AACC 2018 annual meeting.


Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Portable Electronic Pipette
Mini 96
New
Gold Member
Automatic Hematology Analyzer
DH-800 Series
New
Automatic Chemiluminescence Immunoassay Analyzer
Shine i2000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The test could streamline clinical decision-making by identifying ideal candidates for immunotherapy upfront (Xiao, Y. et al. Cancer Biology & Medicine July 2025, 20250038)

Blood Test Predicts Immunotherapy Efficacy in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an aggressive subtype lacking targeted therapies, making immunotherapy a promising yet unpredictable option. Current biomarkers such as PD-L1 expression or tumor... Read more

Technology

view channel
Image: The sensor can help diagnose diabetes and prediabetes on-site in a few minutes using just a breath sample (Photo courtesy of Larry Cheng/Penn State)

Graphene-Based Sensor Uses Breath Sample to Identify Diabetes and Prediabetes in Minutes

About 37 million U.S. adults live with diabetes, and one in five is unaware of their condition. Diagnosing diabetes often requires blood draws or lab visits, which are costly and inconvenient.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.